Evidence map›Paper›PMID 41049382›Full record

ArticleFrontiers in nutrition2025

Unveiling the potential of lactic acid bacteria from Algerian dromedary camel milk: diversity, technological applications, and antimicrobial insights.

Bilal Latreche, Esma Bendjama, Lotfi Loucif, Ibtissem Sanah, Mohammed Messaoudi, Chawki Bensouici, Fairouz Djeghim, Khawla Kerbab, Jean-Marc Rolain, Maria D'Elia and 2 more

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bilal LatrecheLaboratoire de recherche en Sciences Alimentaires, Formulation, Innovation, Valorisation et Intelligence Artificielle (SAFIVIA), Institut de la Nutrition, de l'Alimentation et des Technologies Agro-Alimentaires (INATAA), Université Frères Mentouri Constantine 1, Constantine, Algeria.
Esma BendjamaDépartement de Technologie Alimentaire, Institut des Sciences Vétérinaires et des Sciences Agronomiques, Université Batna 1, Batna, Algeria.
Lotfi LoucifLaboratoire de Biotechnologie des Molécules Bioactives et de la Physiopathologie Cellulaire (LBMBPC), Faculté des Sciences de la Nature et de la Vie, Université Batna 2, Batna, Algeria.
Ibtissem SanahLaboratoire de recherche en Sciences Alimentaires, Formulation, Innovation, Valorisation et Intelligence Artificielle (SAFIVIA), Institut de la Nutrition, de l'Alimentation et des Technologies Agro-Alimentaires (INATAA), Université Frères Mentouri Constantine 1, Constantine, Algeria.
Mohammed MessaoudiLaboratoire de Chimie, Ecole Normale Supérieure - Kouba, Alger, Algeria.
Chawki BensouiciBiotechnology Research Center (CRBt), Constantine, Algeria.
Fairouz DjeghimÉquipe FNPAA, Laboratoire de Nutrition et Technologie Alimentaire (LNTA), Institut de la Nutrition, de l'Alimentation et des Technologies Agro-Alimentaires (INATAA), Université Frères Mentouri Constantine 1, Constantine, Algeria.
Khawla KerbabLaboratoire de Génie Biologique, Valorisation et Innovation des Produits Agro-alimentaires (LGBVIPA), Institut des Sciences et des Techniques Appliquées (ISTA), Ain M'lila, Université Larbi Ben M'hidi, Oum El Bouaghi, Algeria.
Jean-Marc RolainIHU Méditerranée Infection, MEPHI, Faculté de Médecine et de, Pharmacie Aix Marseille Université, Marseille, France.
Maria D'EliaDepartment of Pharmacy, University of Salerno, Salerno, Italy.
Luca RastrelliDepartment of Pharmacy, University of Salerno, Salerno, Italy.
Samira BecilaLaboratoire de recherche en Sciences Alimentaires, Formulation, Innovation, Valorisation et Intelligence Artificielle (SAFIVIA), Institut de la Nutrition, de l'Alimentation et des Technologies Agro-Alimentaires (INATAA), Université Frères Mentouri Constantine 1, Constantine, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lactic acid bacteria (LAB) play a central role in the food industry due to their ability to produce beneficial metabolites and enhance the technological and sensory qualities of fermented products. Additionally, they contribute to human health by supporting immune function and maintaining gut microbiota balance through probiotic effects. This study aimed to isolate and characterize LAB from dromedary camel milk (DCM) collected in semi-arid regions of Algeria, evaluating their technological functionalities and antimicrobial activities. Methods: A total of 31 LAB strains were isolated from raw DCM samples. Strains were identified using MALDI-TOF MS and characterized for acidification kinetics, lipolytic, proteolytic, and amylolytic activities, exopolysaccharide (EPS) and acetoin production, and antimicrobial properties against common foodborne pathogens. Results: Four species were identified, with Conclusion: Dromedary camel milk from Algerian semi-arid regions represents a rich source of LAB strains with promising technological and antimicrobial potential. These native isolates could be further developed for use in additive-free fermented foods and natural biopreservation systems, supporting sustainable and functional food innovation.

Indexed as

antimicrobial activitydromedary camel milklactic acid bacteria (LAB)MALDI-TOF MSmicrobial diversitytechnological properties

Identifiers

PMID41049382
PMCPMC12488446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.